Skip to main content
CG MedTech Co.,Ltd. logo

CG MedTech Co.,Ltd. — Investor Relations & Filings

Ticker · 056090 ISIN · KR7056090004 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2025-03-11 M&A Activity
Country KR South Korea
Listing KO 056090

About CG MedTech Co.,Ltd.

https://cgmedt.com/

CG MedTech Co., Ltd. is a medical technology company that designs, manufactures, and distributes orthopedic medical devices and surgical implants. The company's product portfolio encompasses solutions for spine, trauma, pain management, sports medicine, and biologics. Key offerings include spinal fixation devices, bioabsorbable alloy implants, and systems for fracture treatment. CG MedTech focuses on regenerative medicine and the development of innovative technologies, such as patient-specific 3D printed implants, to enhance tissue regeneration and improve patient outcomes.

Recent filings

Filing Released Lang Actions
주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing a 'Decision on Company Merger' (회사합병 결정) between CGMedTech and its subsidiary GDS. This is a formal regulatory announcement regarding M&A activity, which falls under the 'M&A Activity' category.
2025-03-11 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for shareholder rights (specifically for a small-scale merger objection). It does not contain full financial statements or meeting materials, but rather serves as a formal notice of a corporate action. Since it does not fit into specific categories like dividend announcements or director dealings, and is a standard regulatory disclosure, it falls under the general regulatory filing category.
2025-03-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Siji Meditech) disclosing a significant change (over 15-30%) in financial performance (revenue, operating profit, net income) compared to the previous fiscal year. This is a standard 'Earnings Release' or 'Preliminary Financial Results' announcement required by the Korea Exchange (KRX) for listed companies. It provides key financial highlights and reasons for the variance, fitting the definition of an Earnings Release (ER). FY 2024
2025-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the meeting and the items to be voted upon.
2025-03-11 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing titled '주주총회 집중일 개최 사유 신고' (Report on the reason for holding a general meeting on a concentrated date). It explains why the company, CG Medtech, is holding its shareholder meeting on a date designated as a 'concentrated date' by the KOSDAQ Association. This is a specific regulatory disclosure requirement in the Korean market regarding corporate governance and meeting scheduling, which does not fit into the other specific categories like AGM-R (presentation materials) or PSI (proxy solicitation). Therefore, it is classified as a general regulatory filing.
2025-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for CG MedTech. It contains the agenda for the upcoming Annual General Meeting (AGM), including reports on audit, operations, and internal accounting, as well as proposals for financial statement approval, director appointments, and remuneration limits. It also includes detailed governance information such as board activity and major shareholder transactions. This document is a standard proxy statement/notice of meeting sent to shareholders to inform them of the meeting and solicit their participation/votes. In the provided taxonomy, this fits best under 'Proxy Solicitation & Information Statement' (PSI).
2025-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.